Furthermore, the role of ferroptosisin heart failure is supported by evidence showing that various pharmacologicalagents, such as SGLT2 inhibitors, can reduce ferroptosis and improve cardiacfunction [90]. The gene discussed is SLC5A2; the disease is heart failure.